LONZA N | 599,20 / +0,67% |
Data / Laikas | 22.01. / 17:30 |
Pok. / Pok.(%) | 4,00 / +0,67% |
Bid | 596,00 / 16 |
Ask | - / 2 |
Atidaryti | 592,20 |
Ankstesnį uždaryti | 595,20 |
Aukšč. | 599,40 |
Žem. | 588,20 |
APYVARTA [CHF] | 114.711.253,00 |
APYVARTA [Units] | 192.630 |
Price fixings | 7818 |
ISIN | CH0013841017 |
Simbolis | LONN |
Birža | SIX Swiss Exchange |
Rūšis | Stock |
Visos biržos
Birža | Paskutinis | APYVARTA | |
---|---|---|---|
Lang & Schwa.. | 548,800 | ![]() |
|
SIX Swiss Ex.. | 599,20 | ![]() |
192.630 |
London Inter.. | 599,26 | ![]() |
18.841 |
Nasdaq Other.. | 680,7500 | ![]() |
342 |
Mexico | 13.537,55 | ![]() |
210 |
TradeGate | 294,000 | 298 | |
Frankfurt | 293,9000 | 63 | |
Düsseldorf | 291,20 | 0 | |
München | 291,30 | 0 | |
Berlin | 296,90 | 0 | |
Hamburg | 291,30 | 0 | |
gettex | 296,100 | ||
Singapore | 79,97 | 500 | |
EUREX | Options |
Naujienos
- Capricor Collaborates with Lonza for the Development of CAP-1002, its Cell Therapy Candidate for the Treatment of Duchenne Muscular Dystrophy and Other Indications
12.01.2021 / 15:05 - GlobeNewswire - Achilles Therapeutics Appoints Arjan Roozen as VP, Site Head and General Manager
08.01.2021 / 13:00 - GlobeNewswire - Arbor Biotechnologies and Lonza Enter into Gene Editing Technology Licensing Deal
23.12.2020 / 14:00 - GlobeNewswire - Recro Announces Executive Changes
16.12.2020 / 13:00 - GlobeNewswire - Avid Bioservices Announces Appointment of Jeanne Thoma to Board of Directors
07.12.2020 / 22:05 - GlobeNewswire